Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
8.00
+1.20 (17.65%)
At close: May 14, 2025, 4:00 PM
7.60
-0.40 (-5.00%)
After-hours: May 14, 2025, 4:00 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $52.65 million as of May 14, 2025. Its market cap has increased by 101.74% in one year.
Market Cap
52.65M
Enterprise Value
-13.61M
1-Year Change
101.74%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $52.65M, a decrease of -75.34%. That is a compound annual growth rate of -15.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 44.80M | 34.94% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |